The development of tools to measure insulin resistance using continuous glucose monitoring methods represents a promising approach, as increasing insulin resistance in ICU patients contributes to hyperglycaemia and requires higher insulin doses to maintain glycaemic control despite similar nutritional intake [74, 75]. The gene discussed is INS; the disease is Hyperglycemia.